Selection of candidates for cardiac resynchronization therapy and implantation management: an Italian survey promoted by the Italian Association of Arrhythmology and Cardiac Pacing

Author:

Ziacchi Matteo1,Anselmino Matteo2,Palmisano Pietro3,Casella Michela45,Pelargonio Gemma67,Russo Vincenzo8,D’Onofrio Antonio9,Massaro Giulia10,Vilotta Manola1112,Lauretti Maurilio13,Themistoclakis Sakis14,Boriani Giuseppe15,De Ponti Roberto1112

Affiliation:

1. Cardiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Dipartimento Cardio-toraco-vascolare, Bologna

2. Cardiology Division, ‘Città della Salute e della Scienza di Torino’ Hospital, Department of Medical Sciences, University of Turin, Turin

3. Cardiology Unit, ‘Card. G. Panico’ Hospital, Tricase

4. Cardiology and Arrhythmology Clinic, University Hospital ‘Azienda Ospedaliero-Universitaria delle Marche’

5. Department of Clinical, Special and Dental Sciences, Marche Polytechnic University, Ancona

6. Institute of Cardiology, Catholic University of Sacred Heart

7. Department of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

8. Cardiology and Syncope Unit, Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli

9. Departmental Unit of Electrophysiology, Evaluation and Treatment of Arrhythmias, Monaldi Hospital, Naples

10. Institute of Cardiology, Department of Medical and Surgical Sciences, University of Bologna, Policlinico S.Orsola-Malpighi, Bologna

11. Department of Medicine and Surgery, University of Insubria

12. Cardiology Unit, Ospedale di Circolo, ASST Settelaghi, Varese

13. UOSVD Elettrofisiologia, Ospedale Vito Fazzi, Lecce

14. Cardiology Division, Ospedale dell’Angelo, Mestre (VE)

15. Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy

Abstract

Background Cardiac resynchronization therapy (CRT) represents an effective heart failure treatment, associated with reduction in mortality and heart failure hospitalizations. This Italian survey aimed to address relevant CRT issues. Methods An online survey was administered to AIAC members. Results One hundred and five electrophysiologists participated, with a median of 40 (23–70) CRT implantations/year (33% in high-volume centres). Forty-five percent of respondents (especially working in high-volume centres) reported an increase in CRT implantations in the last 2 years, in 16% a decrease, and in 38% CRT remained stable. Seventy-five percent of respondents implanted CRT only in patients with European Heart Rhythm Association (EHRA) class I indications. All operators collected ECG and echocardiography before implantation. Eighty-five percent of respondents selected coronary sinus target vein empirically, whereas 10% used mechanical and/or electrical delay techniques. Physicians working in high-volume centres reported a lower failure rate compared with others (16 vs. 34%; P = 0.03). If the coronary sinus lead could not be positioned in the target branch, 80% placed it in another vein, whereas 16% opted for a surgical approach or for conduction system pacing (CSP). Eighty percent accomplished CRT optimization in all patients, 17% only in nonresponders. Regarding anticoagulation, high agreement with EHRA guidelines emerged. Conclusion CRT represents a valid therapeutic option in heart failure treatment. Nowadays, CRT implantations remain stable and are mainly performed in patients with class I indications. ECG remains the preferred tool for patient selection, whereas imaging is increasingly used to determine the left pacing target area. In most patients, the left ventricular lead can be successfully positioned in the target vein, but in some cases, the result can be unsatisfactory; however, the decision to explore alternative resynchronization approaches is rarely pursued.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3